| Name | Title | Contact Details |
|---|
Ottobock is a global leader in prosthetic and orthotic medical devices, with 49 branches and 6,000+ employees serving people with mobility challenges around the world. Otto Bock founded the company in Germany in 1919 with the vision of helping people restore and maintain their independence -- and that same vision drives the company today. The US branch was founded in 1958, followed in 1978 by the Canadian branch. The North American region employes nearly 700 people throughout the United States and Canada, with locations in Salt Lake City, UT; Minneapolis, MN; Toronto, ON; Louisville, KY; Tempe, AZ; Sacramento, CA; La Verna, CA; and additional field sales representatives. The company is headquartered in Germany, and includes regions in Western Europe, Eastern Europe/Africa, Asia Pacific and Latin America.
Patrick Treacy, Antony Koblish and Adele Oliva saw a unique opportunity for one company to demonstrate leadership and set the agenda for innovation in surgical oncology. Founded in 2015, with best-in-class innovation partners, Onkos Surgical will deliver high quality implants and instruments that meet the unique needs of musculoskeletal tumor patients. From modular segmental systems to customized solutions and patient specific products, Onkos Surgical will partner with surgeons to provide new innovations to help address complex cases. Onkos Surgical has capabilities to increase the speed and delivery of innovation. Onkos Surgical is leveraging new technologies, such as 3D printing, to meet the unique needs of the cancer patient or surgeon. Onkos Surgical will develop products for both hard and soft-tissue applications while continuing to explore strategic partnerships to differentiate our product portfolio. With great customer responsiveness, manufacturing lead-times and quality, our vision is to be able to service and support the needs of the surgical oncologist.
Specialized Engineering is a Stockton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 100,000 implanted to date.
GN Otometrics North America is a Schaumburg, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.